Business context and reporting period
Research Alliance Corporation III, a Cayman Islands special purpose acquisition company, reported that it completed its initial public offering and related private placement on May 21, 2026. The 8-K was filed May 28, 2026.
Key financial and transaction metrics
- IPO: 7,500,000 Class A ordinary shares sold at $10.00 per share, for gross proceeds of $75,000,000 before underwriting discounts, commissions, and offering expenses.
- Private placement: Sponsor purchased 275,000 Class A ordinary shares at $10.00 per share, generating $2,750,000 gross proceeds.
- Trust account: The company reported that $75,000,000 of net proceeds from the IPO and private placement, including the underwriter’s $2,250,000 deferred commission, was deposited in trust for public shareholders. Continental Stock Transfer & Trust Company is trustee.
- The filing text does not provide operating revenue, profit, cash flow, margins, debt, or other liquidity metrics. It refers to an audited balance sheet as of May 21, 2026, included as Exhibit 99.1, but that balance sheet is not reproduced in the supplied text.
Material changes versus prior period
The filing describes the company’s IPO and private placement closing; it provides no prior-period financial results for comparison.
Outlook, risks, contingencies, and unusual items
No guidance, business outlook, or specific risks or contingencies are discussed in the supplied filing text. The $2,250,000 deferred underwriting commission is included in the amount reported as deposited in trust.
Important facts to verify
- Review Exhibit 99.1 for the audited balance sheet and the detailed accounting for offering proceeds and expenses.
- Confirm the trust-account balance, including how the deferred commission is presented.
- Verify the share issuance totals and any applicable redemption or business-combination terms in the company’s other filings.